Erratum: p122 protein enhances intracellular calcium increase to acetylcholine: Its possible role in the pathogenesis of coronary spastic angina (Arteriosclerosis, Thrombosis, and Vascular Biology (2010) 30 (1968-1975) DOI: 10.1161/ATVBAHA.110.203083);P122 protein enhances intracellular calcium increase to acetylcholine: Its possible role in the pathogenesis of coronary spastic angina

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 30, Issue 10, 2010, Pages 1968-1975

  Murakami, Reiichi ^a   Osanai, Tomohiro ^a   Tomita, Hirofumi ^a   Sasaki, Satoko ^a   Maruyama, Atsushi ^a   Itoh, Ken ^a   Homma, Yoshimi ^b   Okumura, Ken ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

calcium ion; coronary spasm; p122 protein; PLC 1; vascular biology; vasoconstriction

Indexed keywords

ACETYLCHOLINE; CALCIUM; GENOMIC DNA; LUCIFERASE; PROTEIN; PROTEIN P122; UNCLASSIFIED DRUG; DLC1 PROTEIN, HUMAN; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; PHOSPHOLIPASE C DELTA; PLCD1 PROTEIN, HUMAN; PRIMER DNA; SMALL INTERFERING RNA; TUMOR SUPPRESSOR PROTEIN;

ADULT; ANGINA PECTORIS; ARTICLE; CALCIUM CELL LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY SPASM; FEMALE; GENE EXPRESSION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKIN FIBROBLAST; ANIMAL; ANTAGONISTS AND INHIBITORS; CASE CONTROL STUDY; CELL CULTURE; CELL LINE; CORONARY VASOSPASM; DRUG EFFECTS; FIBROBLAST; GENE SILENCING; GENETIC TRANSFECTION; GENETICS; METABOLISM; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PROMOTER REGION; RAT;

ACETYLCHOLINE; ANGINA PECTORIS; ANIMALS; BASE SEQUENCE; CALCIUM; CASE-CONTROL STUDIES; CELL LINE; CELLS, CULTURED; CORONARY VASOSPASM; DNA PRIMERS; FEMALE; FIBROBLASTS; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; GENETIC VARIATION; GTPASE-ACTIVATING PROTEINS; HUMANS; MALE; MIDDLE AGED; PHOSPHOLIPASE C DELTA; PROMOTER REGIONS, GENETIC; RATS; RNA, SMALL INTERFERING; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

EID: 77957706782     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATV.0b013e3181fdc67e     Document Type: Erratum

References (22)

1. Oliva PB, Potts DE, Pluss RG. Coronary artery spasm in Prinzmetal angina: documentation by coronary angiography. N Engl J Med. 1973; 288:745-751.
2. Yasue H, Touyama M, Shimamoto M, Kato H, Tanaka S. Role of autonomic nervous system in the pathogenesis of Prinzmetal's variant form of angina. Circulation. 1974;50:534-539.
3. Maseri A, L'Abbate A, Baroldi G, Chierchia S, Marzilli M, Ballestra AM, Severi S, Parodi O, Biagini A, Distante A, Pesola A. Coronary vasospasm as a possible cause of myocardial infarction: a conclusion derived from the study of preinfarction angina. N Engl J Med. 1978;299:1271-1277.
4. Rasmussen K, Ravnsbaek J, Funch-Jensen P, Baqqer JP. Oesophageal spasm in patients with coronary artery spasm. Lancet. 1986;1:174-176.
5. Korn ED, Hammer JA. Myosins of nonmuscle cells. Annu Rev Biophys Chem. 1988;17:23-45.
6. 2+-dependent binding of the pleckstrin homology domain to phosphoinositides. Eur J Biochem. 1999;265:481-490.
7. Kim YH, Park TJ, Lee YH, Baek KJ, Suh PG, Ryu SH, Kim KT. Phospholipase C-S1 is activated by capacitative calcium entry that follows phospholipase C-ß activation upon bradykinin stimulation. J Biol Chem. 1999;274:26127-26134.
8. Clarke CJ, Forman S, Pritchett J, Ohanian V, Ohanian J. Phospholipase C-S1 modulates sustained contraction of rat mesenteric small arteries in response to noradrenaline, but not endothelin-1. Am J Physiol Heart Circ Physiol. 2008;295:H826-H834.
9. Ochocka AM, Grden M, Sakowicz-Burkiewicz M, Szutowicz A, Pawelczyk T. Regulation of phospholipase C-S1 by ARHGAP6, a GTPase-activating protein for RhoA: possible role for enhanced activity of phospholipase C in hypertension. Int J Biochem Cell Biol. 2008;40: 2264-2273.
10. Okumura K, Osanai T, Kosugi T, Hanada H, Ishizaka H, Fukushi T, Kamada T, Miura T, Hatayama T, Nakano T, Fujino Y, Homma Y. Enhanced phospholipase C activity in the cultured skin fibroblast obtained from patients with coronary spastic angina: possible role for enhanced vasoconstrictor response. J Am Coll Cardiol. 2000;36: 1847-1852.
11. Nakano T, Osanai T, Tomita H, Sekimata M, Homma Y, Okumura K. Enhanced activity of variant phospholipase C-S1 protein (R257H) detected in patients with coronary artery spasm. Circulation. 2002;105: 2024-2029.
12. Sekimata M, Kabuyama Y, Emori Y, Homma Y. Morphological changes and detachment of adherent cells induced by p122, a GTPase-activating protein for Rho. J Biol Chem. 1999;274:17757-17762.
13. Yamaga M, Sekimata M, Fujii M, Kawai K, Kamata H, Hirata H, Homma Y, Yagisawa H. A PLCS1-binding protein, p122/RhoGAP, is localized in caveolin-enriched membrane domains and regulates caveolin internalization. Genes Cells. 2004;9:25-37.
14. Homma Y, Emori Y. A dual functional signal mediator showing RhoGAP and phospholipase C-8 stimulating activities. EMBO J. 1995;14: 286-291.
15. 2+ mobilization through distinct pathways. EMBO J. 1994; 13:1341-1349.
16. Osanai T, Dunn MJ. Phospholipase C responses in cells from spontaneously hypertensive rats. Hypertension. 1992;19:446-455.
17. Okumura K, Yasue H, Matsuyama K, Ogawa H, Kugiyama K, Ishizaka H, Sumida H, Fujii H, Matsunaga T, Tsunoda R. Diffuse disorder of coronary artery vasomotility in patients with coronary spastic angina: hyperreactility to the constrictor effects of acetylcholine and the dilator effects of nitroglycerin. J Am Coll Cardiol. 1996;27:45-52.
18. Okumura K, Yasue H, Matsuyama K, Goto K, Miyagi H, Ogawa H, Matsuyama K. Sensitivity and specificity of intracoronary injection of acetylcholine for the induction of coronary artery spasm. J Am Coll Cardiol. 1988;12:883-888.
19. Hoshio A, Kotake H, Mashiba H. Significance of coronary artery tone in patients with vasospastic angina. J Am Coll Cardiol. 1989;14:604-609.
20. Kaski JC, Crea F, Meran D, Rodriguez L, Araujo L, Chierchia S, Davies G, Maseri A. Local coronary supersensitivity to diverse constrictive stimuli in patients with variant angina. Circulation. 1986;74:1255-1265.
21. Masumoto A, Mohri M, Shimokawa H, Urakami L, Usui M, Takeshita A. Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina. Circulation. 2002;105:1545-1547.
22. 2+-dependent activation of Rho and Rho kinase in membrane depolarization-induced and receptor stimulation-induced vascular smooth muscle contraction. Circ Res. 2003;93:548-556.